Red Journal Podcast October 1, 2022
Dr. Jeffrey Olsen, Associate Professor of Radiation Oncology at the University of Colorado and section editor of our gastrointestinal section, co-leads a discussion along with our Editor-in-Chief Dr. Sue Yom, with Dr. Nima Nabavizadeh, Associate Professor of Radiation Medicine at the Oregon Health and Science University, the supervising author of "Low Utilization of External Beam Radiation Therapy for Patients With Unresectable Hepatocellular Carcinoma: An Analysis of the United Network for Organ Sharing Database" and Dr. Michael Buckstein, Associate Professor of Radiation Oncology at Mount Sinai Medical Center, also an editor at the Red Journal and the lead author of "Combination Transarterial Chemoembolization and Stereotactic Body Radiation Therapy for Unresectable Single Large Hepatocellular Carcinoma: Results From a Prospective Phase 2 Trial." We discuss indications for EBRT/SBRT for hepatocellular carcinoma in the contemporary context of collaborating and competing liver-directed therapies.